SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage ...
The Canadian market has shown strong momentum as it heads into 2025, supported by resilient consumer spending and rising corporate profits, although potential curveballs remain a consideration for ...